The new Biotech Act, presented by the European Commission, aims to set up a framework that helps biotechnology reach the market faster, improving the bloc’s competitiveness over China, and the United States.
The Commission on Tuesday acknowledged in its proposal that the European Union (EU) lags behind other global regions when it comes to turning its science and innovation into commercially viable products and large-scale manufacturing.
